Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix s clinical product development initiatives include Topical Interferon Alpha b, for the treatment of conditions caused by the human papilloma virus. Helix is also developing its novel L DOS new drug product candidate for the treatment of lung adenocarcinoma.
Quote | Helix Biopharma Corp (OTCMKTS:HBPCF)
Last: | $0.1377 |
---|---|
Change Percent: | -0.07% |
Open: | $0.1378 |
Close: | $0.1377 |
High: | $0.1378 |
Low: | $0.1377 |
Volume: | 287 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Helix Biopharma Corp (OTCMKTS:HBPCF)
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Message Board Posts | Helix Biopharma Corp (OTCMKTS:HBPCF)
Subject | By | Source | When |
---|---|---|---|
HBPC changed to HBPCF: | Renee | investorshub | 04/01/2013 8:43:22 PM |
Helix BioPharma delisted from AMEX to OTC. Ticker | Renee | investorshub | 07/19/2012 9:38:14 PM |
Helix BioPharma approves the selection of Director Robert | mlkrborn | investorshub | 06/26/2012 2:50:49 PM |
Helix BioPharma provides update to shareholders; appoints William | mlkrborn | investorshub | 04/09/2012 2:13:51 PM |
Helix BioPharma Corp. Announces Appointment of Special Committee | mlkrborn | investorshub | 11/17/2011 2:53:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Helix Biopharma Corp Company Name:
HBPCF Stock Symbol:
OTCMKTS Market:
Helix Biopharma Corp Website:
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...